Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alpha4 integrins as therapeutic targets in autoimmune disease.

× No keyword cloud information.

82 in total

Review 1. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

Authors: Brian J Nickoloff; Frank O Nestle
Journal: J Clin Invest Date: 2004-06 Impact factor: 14.808

2. How do you know?

Authors: J T Rosenbaum; A Deodhar; E B Suhler; J R Smith
Journal: Br J Ophthalmol Date: 2004-08 Impact factor: 4.638

Review 3. The regulation of integrin function by divalent cations.

Authors: Kun Zhang; JianFeng Chen
Journal: Cell Adh Migr Date: 2012 Jan-Feb Impact factor: 3.405

4. Innovative monoclonal antibody therapies in multiple sclerosis.

Authors: Ralf A Linker; Bernd C Kieseier
Journal: Ther Adv Neurol Disord Date: 2008-07 Impact factor: 6.570

Review 5. Factors controlling permeability of the blood-brain barrier.

Authors: Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal: Cell Mol Life Sci Date: 2015-09-24 Impact factor: 9.261

Review 6. Intraepithelial lymphocytes: to serve and protect.

Authors: Brian S Sheridan; Leo Lefrançois
Journal: Curr Gastroenterol Rep Date: 2010-12

7. Natalizumab in the treatment of multiple sclerosis.

Authors: Ozgür Yaldizli; Norman Putzki
Journal: Ther Adv Neurol Disord Date: 2009-03 Impact factor: 6.570

Review 8. Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors: Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal: Inflamm Bowel Dis Date: 2008-12 Impact factor: 5.325

9. How natalizumab binds and antagonizes α4 integrins.

Authors: Yamei Yu; Thomas Schürpf; Timothy A Springer
Journal: J Biol Chem Date: 2013-09-18 Impact factor: 5.157

Review 10. [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors: H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal: Nervenarzt Date: 2004-06 Impact factor: 1.214